Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Fervo Energy, a Nasdaq-listed independent power producer specializing in enhanced geothermal systems, reported its first quarter 2026 financial and operational results. The company successfully completed a $2.2 billion IPO, advancing multiple geothermal projects including Cape Station Phase I and Phase II, and secured a significant framework agreem…
Digital Realty announced a series of strategic transactions to support its growth pillars: acquiring 1,440 acres near Kansas City for hyperscale data center development, increasing ownership in Africa's leading data center platform Teraco to 77%, and acquiring Columbia Capital to enhance its Strategic Private Capital platform. These moves strengthe…
Seer, Inc. announced preliminary data presented at ASMS 2026 demonstrating its Proteograph Product Suite's ability to enable AI-driven approaches for large-scale, deep plasma proteomics in multi-cancer screening. Collaborating with Korea University, Seer showcased data from over 5,500 plasma samples across ten cancer types, leveraging advanced AI t…
Ligand Pharmaceuticals announced a proposed private placement of $550 million in convertible senior notes due 2031. The company plans to use portions of the proceeds to repurchase shares and fund convertible note hedging transactions to offset potential dilution. Remaining proceeds will support general corporate purposes, including investments and …
Eledon Pharmaceuticals released long-term data from its Phase 2 BESTOW clinical trial demonstrating that tegoprubart, an investigational anti-CD40L antibody, maintained superior kidney function compared to tacrolimus in kidney transplant recipients, with significantly higher eGFR at 18 months and no biopsy-proven acute rejection events after six mo…
Traws Pharma is preparing an updated toxicology data submission to the UK MHRA for its oral antiviral candidate tivoxavir marboxil (TXM), which is planned to enter a Phase 2a influenza challenge study. The updated data package aims to address MHRA's requirements and support proof of concept for TXM as a prophylactic against seasonal influenza. The …
MapLight Therapeutics announced topline results from the Phase 2 IRIS study evaluating ML-004 in autism spectrum disorder. While the primary endpoint related to social communication deficits was not met, a prespecified analysis revealed meaningful improvement in irritability symptoms among adolescents with moderate to severe baseline irritability. …
Auddia Inc. announced engineering and deployment plans for its LT350 project, which transforms parking lots into distributed AI datacenters via a modular solar canopy platform integrating GPUs and batteries. Fresh Consulting has been engaged to lead the thermal, power, battery, and GPU integration design. This milestone progresses LT350 from concep…
Regeneron Pharmaceuticals announced that the FDA and EMA have accepted the regulatory submissions for cemdisiran, a potential first siRNA treatment for generalized myasthenia gravis (gMG). The FDA is conducting a Priority Review with a target decision date in November 2026, and a European decision is expected in the second half of 2027. Cemdisiran …
Sparklight, a leading US broadband provider, announced the distribution of more than $125,000 in grants to 28 nonprofits as part of its Charitable Giving Fund which totals $250,000 annually. The fund supports initiatives in education and digital literacy, food insecurity, and community development across its service areas. Since 2020, Sparklight ha…
NRx Pharmaceuticals received FDA approval for an Expanded Access Protocol allowing compassionate use of NRX-101, a combination of D-cycloserine and lurasidone, to augment Transcranial Magnetic Stimulation (TMS) therapy in treatment-resistant depression patients. The company is concurrently conducting a pivotal clinical trial assessing NRX-101's eff…
TScan Therapeutics announced positive initial results from Cohort C of its ongoing ALLOHA Phase 1 study evaluating TSC-101 in patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation. The therapy showed a high rate of complete donor chimerism shortly after infusion and was well tolerated. The company is on tra…
Brunswick Corporation's division, Navico Group, disclosed operational changes at its Lowell, Michigan facility aimed at reducing fixed costs, improving efficiency, and supporting long-term growth. The plan includes expanding insourcing, collaborating more closely with other Brunswick divisions, and utilizing space for Land ‘N’ Sea's distribution op…
Lithium Argentina AG held its 2026 Annual General Meeting where shareholders re-elected eight directors, approved the 2025 financial statements, approved an amended equity incentive plan, and confirmed compensation and auditor appointments. These corporate governance actions position the company for continued operation and oversight of its lithium …
GXO Logistics announced it will manage operations at a new distribution center in Ferentino, Italy, supporting Action’s expansion across Central and Southern Italy. The facility emphasizes sustainability with a BREEAM Outstanding certification and features energy-efficient technologies. This expansion strengthens GXO's partnership with Action and e…
DMC Global Inc.'s NobelClad business has expanded its manufacturing capabilities in the Americas by adding weld overlay services. This new turnkey service complements NobelClad's existing clad metal solutions by enhancing corrosion resistance and wear protection for critical industrial equipment, particularly in the oil and gas, chemical processing…
SpaceX’s debut as a publicly listed company ignited intense market activity, with shares climbing nearly 40% from the June 12 IPO price of $135 and briefly pushing the firm’s market value above $2 trillion. High retail participation, outsized turnover and a surge in options trading marked the first week, followed by a period of volatility in the la…
Ferrari has denied reports that customers must buy its new Luce electric vehicle to qualify for future limited-edition models. Chief Marketing and Commercial Officer Enrico Galliera said making access conditional on Luce ownership would risk turning buyers into negative ambassadors, undermining resale values and damaging the luxury EV segment alrea…
Recent U.S. limits on access to certain AI models are driving major European companies to accelerate diversification across U.S., Chinese and European providers, while reinforcing calls for controllable domestic alternatives. Executives at VivaTech said firms already mix open-weight and proprietary models to reduce single-vendor exposure, even as r…
Evercore ISI recommends a handful of S&P 500 names that exhibit negative beta characteristics as a way for investors heavily concentrated in AI-related stocks to diversify without exiting equities. Analyst Julian Emanuel highlighted elevated single-stock volatility, low implied correlations, and a growing roster of stocks trading inversely to the S…
Germany’s leading industry association, the BDI, sharply reduced its growth outlook for 2026 and cautioned that the country’s industrial sector is under intense pressure from elevated costs, weak investment conditions and geopolitical shocks. The association called for a comprehensive reform package to restore competitiveness, including lower corpo…
Alamos Gold Inc. announced exploration drilling results at its Island Gold Mine, including the discovery of new high-grade gold mineralization zones such as the Island West Extension and up-plunge areas. These findings suggest expanded resources and support increased underground mining rates and mill feed quality, aligning with the ongoing expansio…
Early diplomatic signals from Switzerland eased pressure on oil markets on Monday, pushing Brent crude back below $80 per barrel after weekend threats and Iranian claims over the Strait of Hormuz. At the same time, a sudden resignation in UK politics has set in motion a leadership contest that will deliver Britain its seventh prime minister in a de…
Regenxbio shares climbed in pre-market trading after reports indicated the FDA has agreed to reverse its previous rejection of Navsunli (RGX-121, clemidsogene lanparvovec) for Mucopolysaccharidosis Type II. The company intends to refile its Biologics License Application in the third quarter of 2026 and expects a formal meeting with regulators in Ju…
Methanex is the world’s largest methanol supplier and is starting Q2 with meaningful pricing tailwinds. With management reporting Q1 Adjusted EBITDA of $220M, expected spot methanol at $500-$525/tonne in Q2, and a net-cash rebuilding trend, the company can convert higher realized prices into stronger cash flow. Technicals show the stock oversold an…
